Association of PIK3CA mutation with outcomes in HER2-positive breast cancer treated with anti-HER2 therapy: A meta-analysis and bioinformatic analysis of TCGA‑BRCA data

BACKGROUND: This study aimed to comprehensively explore the clinical significance of PIK3CA mutation in human epidermal growth factor receptor 2 (HER2)-positive breast cancer treated with anti-HER2 therapy. METHODS: We systematically searched PubMed, Embase, and the Cochrane databases for eligible s...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Haizhu, Hu, Xingbin, Wang, Daquan, Wang, Ying, Yu, Yunfang, Yao, Herui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458974/
https://www.ncbi.nlm.nih.gov/pubmed/37597296
http://dx.doi.org/10.1016/j.tranon.2023.101738

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458974/
https://www.ncbi.nlm.nih.gov/pubmed/37597296
http://dx.doi.org/10.1016/j.tranon.2023.101738

Ejemplares similares